|
× |
 |
Characteristics of the Retrospectively Assessed Prodromal Period in Hospitalized Patients With First-Episode Nonaffective Psychosis: Findings From a Socially Disadvantaged, Low-Income, Predominantly African American Population PDF |
$40.00 |
|
$40.00 |
|
× |
|
Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Integrated Analysis of Acute Treatment-Emergent Extrapyramidal Syndrome in Patients With Schizophrenia During Olanzapine Clinical Trials: Comparisons With Placebo, Haloperidol, Risperidone, or Clozapine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Obesity: Its Epidemiology, Comorbidities, and Management PDF |
$40.00 |
|
$40.00 |
|
× |
|
Switching From Depot Antipsychotic Drugs to Olanzapine in Patients With Chronic Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Acute Swedish Massage Monotherapy Successfully Remediates Symptoms of Generalized Anxiety Disorder: A Proof-of-Concept, Randomized Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychotherapies for Panic Disorder: A Tale of Two Sites PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Multimedia Description of Catatonia Secondary to Anti–NMDA-Receptor Encephalitis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Paroxetine in the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Excessive Antipsychotic Dosing in 2 U.S. State Hospitals PDF |
$40.00 |
|
$40.00 |
|
× |
|
Comorbidity and Quality of Life in DSM-5 Social Anxiety Disorder Among a Nationally Representative Sample PDF |
$40.00 |
|
$40.00 |
|
|
